$13.16
0.30%
NYSE, Oct 05, 04:20 pm EDT. Closed.
ISIN
US90364P1057
Symbol
PATH

UiPath Target price 2026 - Analyst rating & recommendation

UiPath Classifications & Recommendation

Buy
32%
Hold
64%
Sell
4%

UiPath Price Target

Target Price $16.83
Price $13.16
Potential
Number of Estimates 21
21 Analysts have issued a price target UiPath 2027 . The average UiPath target price is $16.83. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 28 analysts: 9 Analysts recommend UiPath to buy, 18 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the UiPath stock has an average upside potential 2027 of . Most analysts recommend the UiPath stock at Hold.

Sales and Margin forecast 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Jan '26 2027
Estimates
Revenue Billion $ 1.61 1.84
12.65% 13.93%
EBITDA Margin 4.03% 27.54%
142.29% 583.23%
Net Margin 17.53% 22.83%
440.10% 30.24%

25 Analysts have issued a sales forecast UiPath 2027 . The average UiPath sales estimate is

$1.8b
unlock
. This is
6.63% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.0b 18.72%
unlock
, the lowest is
$1.7b 1.29%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 $1.6b 12.65%
2027
$1.8b 13.93%
unlock
2028
$2.0b 8.56%
unlock
2029
$2.1b 7.18%
unlock

15 Analysts have issued an UiPath EBITDA forecast 2027. The average UiPath EBITDA estimate is

$505m
unlock
. This is
205.84% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$612m 270.14%
unlock
, the lowest is
$431m 161.00%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 $64.9m 147.64%
2027
$505m 678.36%
unlock
2028
$551m 9.07%
unlock
2029
$626m 13.49%
unlock

EBITDA Margin

2026 4.03% 142.29%
2027
27.54% 583.23%
unlock
2028
27.67% 0.47%
unlock
2029
29.30% 5.89%
unlock

25 UiPath Analysts have issued a net profit forecast 2027. The average UiPath net profit estimate is

$419m
unlock
. This is
15.73% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$468m 29.42%
unlock
, the lowest is
$359m 0.81%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 $282m 483.13%
2027
$419m 48.35%
unlock
2028
$490m 16.96%
unlock
2029
$560m 14.34%
unlock

Net Margin

2026 17.53% 440.10%
2027
22.83% 30.24%
unlock
2028
24.59% 7.71%
unlock
2029
26.24% 6.71%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Jan '26 2027
Estimates
Earnings Per Share $ 0.52 0.81
500.00% 55.77%
P/E 16.23
EV/Sales 3.03

25 Analysts have issued a UiPath forecast for earnings per share. The average UiPath EPS is

$0.81
unlock
. This is
17.39% higher
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
$0.90 30.43%
unlock
, the lowest is
$0.69 0.00%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 $0.52 500.00%
2027
$0.81 55.77%
unlock
2028
$0.95 17.28%
unlock
2029
$1.08 13.68%
unlock

P/E ratio

Current 19.01 93.77%
2027
16.23 14.64%
unlock
2028
13.88 14.48%
unlock
2029
12.14 12.54%
unlock

Based on analysts' sales estimates for 2027, the UiPath stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.23 4.15%
2027
3.03 6.30%
unlock
2028
2.79 7.88%
unlock
2029
2.60 6.70%
unlock

P/S ratio

Current 3.97 8.28%
2027
3.73 6.22%
unlock
2028
3.43 7.88%
unlock
2029
3.20 6.70%
unlock

Current UiPath Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
DA Davidson
Locked
➜
Locked
Locked Sep 28 2026
UBS
Locked
➜
Locked
Locked Sep 25 2026
Canaccord Genuity
Locked
➜
Locked
Locked Sep 24 2026
TD Cowen
Locked
➜
Locked
Locked Sep 24 2026
BMO Capital
Locked
➜
Locked
Locked Sep 24 2026
Needham
Locked
➜
Locked
Locked Sep 23 2026
TD Cowen
Locked
➜
Locked
Locked Sep 23 2026
Analyst Rating Date
Locked
DA Davidson:
Locked
➜
Locked
Sep 28 2026
Locked
UBS:
Locked
➜
Locked
Sep 25 2026
Locked
Canaccord Genuity:
Locked
➜
Locked
Sep 24 2026
Locked
TD Cowen:
Locked
➜
Locked
Sep 24 2026
Locked
BMO Capital:
Locked
➜
Locked
Sep 24 2026
Locked
Needham:
Locked
➜
Locked
Sep 23 2026
Locked
TD Cowen:
Locked
➜
Locked
Sep 23 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today